Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan plus dexketoprofen versus frovatriptan alone for acute migraine treatment
2009-011577-32Phase 3Completed
- Sponsor
- Istituto Lusofarmaco
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of frovatriptan and dexketoprofen in migraine with aura and migraine without aura (3 arms), sponsored by Istituto Lusofarmaco. Primary endpoint: Pain-free at 2 hours before rescue medication. Started Jun 2009; status: completed.
02
Drugs
frovatriptandexketoprofen
03
Conditions
migraine with auramigraine without aura
Beyond the preview
Go deeper on 2009-011577-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011577-32.